In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...